Physician

Robert Azizi, MD

According to 2025 Medicare claims, Robert Azizi, MD (NPI: 1316101298) practices diagnostic radiology in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is ROBERT AZIZI, MD INC. (NPI: 1003402884; TIN: 832865979) and primary practice location at 90201-9998.

Azizi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 312 traditional Medicare patients, billed 11,831 HCPCS/CPT codes, and received $13,159,145 in Medicare payments. The top billing code was 36466 (Injection of chemical agent into multiple incompetent veins of same leg using ultrasound guidance). Part D data shows 236 prescription claims across 87 beneficiaries totaling $48,288 in drug costs, led by Xarelto (Rivaroxaban). Open Payments data shows 12 records totaling $30,752. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $97,328 to $13,159,145. Similarly, Part D prescription costs have moved sharply higher in recent years, from $6,408 to $48,288. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$6.6M$13M2016 Medicare payment: $97,328 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $174,369 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $486,349 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,678,272 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,259,571 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,926,810 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,073,684 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,456,695 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $13,159,145 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
20161,8393,179$97,328
20173,2789,205$174,369
20182,0919,688$486,349
20192185,985$2,678,272
20201602,107$1,259,571
20213204,301$1,926,810
20223414,477$2,073,684
20233414,129$1,456,695
202431211,831$13,159,145

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$24K$48K2019 Drug cost: $6,408 (USD; Tot_Drug_Cst)2020 Drug cost: $3,479 (USD; Tot_Drug_Cst)2021 Drug cost: $11,208 (USD; Tot_Drug_Cst)2022 Drug cost: $24,190 (USD; Tot_Drug_Cst)2023 Drug cost: $43,258 (USD; Tot_Drug_Cst)2024 Drug cost: $48,288 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20192850$6,408
202057111$3,479
202178170$11,208
202284187$24,190
202366157$43,258
202487236$48,288

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
36466Injection of chemical agent into multiple incompetent veins of same leg using ultrasound guidance153345$1,257
93970Ultrasound study of arm or leg veins with compression and maneuvers256394$146
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more126126$119
93971Ultrasound study of one arm or leg veins with compression and maneuvers138269$97
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more254889$95

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XareltoRivaroxaban562,113$39,037
CelecoxibCelecoxib371,200$1,578
ClopidogrelClopidogrel Bisulfate652,972$345
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen25154$113
CephalexinCephalexin17172$57

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.12$30,752AngioDynamics, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Robert Azizi, MD?

Tedicare shows public-source Medicare data for Robert Azizi, MD (NPI 1316101298), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert Azizi, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert Azizi, MD?

Robert Azizi, MD is linked to ROBERT AZIZI, MD INC. (billing NPI 1003402884) in the available physician profile data.

Does Robert Azizi, MD have Open Payments data?

Robert Azizi, MD has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.